Axonics® Granted Seven New U.S. Patents Related to its Implantable Sacral Neuromodulation Technology
4 December 2017
Axonics Modulation Technologies, Inc., developer of the first rechargeable Sacral Neuromodulation (r-SNM™) system for the treatment of bladder and bowel dysfunction, announced today that the